Anavex Life Sciences Corp (AVXL)

[A_Good_Day_2]

From the PR on 2/19/16:

"Studies to determine the relative roles of S-1R agonism, NMDAR antagonism and muscarinic activities are objectives for future studies. ANAVEX2-73 and DM are small molecules that enter the central nervous system and thus have potential to provide protection of OL in MS."

I'd expect the upcoming presentation to answer the above question.

Here's a link to the original poster:
https://actrims.confex.com/actrims/2016/meetingapp.cgi/Paper/1218